PBE Holdings Information

PBE is an equity ETF with a total of 32 individual holdings. The top holdings are Gilead Sciences stock at 6.29%, Biogen at 5.74%, Amgen at 5.69%, Regeneron Pharmaceuticals at 5.35%, and United Therapeutics at 5.18%.

Total Holdings

Top 10 Percentage

48.89%

Asset Class

Equity

ETF Category

Health

Assets

258.37M

PE Ratio

22.35

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	6.29%	107,276
2	BIIB	Biogen Inc.	5.74%	76,001
3	AMGN	Amgen Inc.	5.69%	40,199
4	REGN	Regeneron Pharmaceuticals, Inc.	5.35%	17,649
5	UTHR	United Therapeutics Corporation	5.18%	28,161
6	INCY	Incyte Corporation	4.93%	126,491
7	ILMN	Illumina, Inc.	4.72%	106,688
8	FOLD	Amicus Therapeutics, Inc.	4.11%	741,162
9	ALNY	Alnylam Pharmaceuticals, Inc.	3.69%	30,948
10	RPRX	Royalty Pharma plc	3.19%	184,405
11	MNKD	MannKind Corporation	3.11%	1,428,868
12	BMRN	BioMarin Pharmaceutical Inc.	3.06%	132,074
13	QGEN	Qiagen N.V.	3.06%	155,441
14	IONS	Ionis Pharmaceuticals, Inc.	2.95%	93,353
15	HALO	Halozyme Therapeutics, Inc.	2.95%	99,056
16	EXEL	Exelixis, Inc.	2.86%	173,494
17	CPRX	Catalyst Pharmaceuticals, Inc.	2.84%	311,787
18	BCRX	BioCryst Pharmaceuticals, Inc.	2.82%	1,073,219
19	COLL	Collegium Pharmaceutical, Inc.	2.81%	160,836
20	TECH	Bio-Techne Corporation	2.66%	115,453
21	PTGX	Protagonist Therapeutics, Inc.	2.65%	83,592
22	ACAD	ACADIA Pharmaceuticals Inc.	2.56%	306,699
23	TGTX	TG Therapeutics, Inc.	2.51%	228,851
24	PTCT	PTC Therapeutics, Inc.	2.51%	91,821
25	VCEL	Vericel Corporation	2.48%	188,531

Showing 25 of 32 holdings

Subscribe to see the full list

Activate Now

As of Feb 12, 2026